How has been the historical performance of the Brooks Lab.?

Jun 09 2025 10:36 PM IST
share
Share Via
Brooks Lab. has shown fluctuating financial performance, with net sales increasing to Rs 82.56 crore in March 2025, but still reporting a negative profit after tax of Rs 3.01 crore. While there are signs of recovery in revenue and operating profit, challenges in overall profitability and cash flow persist.
Answer:
The historical performance of Brooks Lab. shows a fluctuating trend in key financial metrics over the years.

Breakdown:
Brooks Lab. experienced net sales of Rs 82.56 crore in March 2025, an increase from Rs 79.49 crore in March 2024 and Rs 63.20 crore in March 2023, although it was lower than Rs 91.08 crore in March 2022. The total operating income followed a similar pattern, reaching Rs 82.56 crore in March 2025. The total expenditure, excluding depreciation, decreased to Rs 77.62 crore in March 2025 from Rs 76.23 crore in March 2024, down from Rs 89.62 crore in March 2023 and Rs 105.44 crore in March 2022. This resulted in an operating profit (PBDIT) of Rs 5.82 crore in March 2025, improving from Rs 4.18 crore in March 2024, and a significant recovery from a loss of Rs 26.22 crore in March 2023. However, the profit after tax remained negative at Rs 3.01 crore in March 2025, although it was an improvement from Rs 1.53 crore in March 2024 and a loss of Rs 27.74 crore in March 2023. The consolidated net profit also showed a loss of Rs 9.97 crore in March 2025, but this was less severe than the losses of Rs 19.59 crore in March 2024 and Rs 20.90 crore in March 2023. The company's total assets decreased to Rs 90.45 crore in March 2024 from Rs 109.60 crore in March 2023, while total liabilities also fell to Rs 90.45 crore in March 2024 from Rs 109.60 crore in March 2023. The cash flow from operating activities was negative at Rs 9.00 crore in March 2024, consistent with the negative cash flows observed in the previous years. Overall, Brooks Lab. has shown signs of recovery in revenue and operating profit, but continues to face challenges in profitability and cash flow management.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News